跳至主要内容
临床试验/NCT01110733
NCT01110733已完成不适用

Prospective, Longitudinal, Multinational Registry of Patients With Newly Diagnosed Peripheral T-Cell Lymphoma

Acrotech Biopharma Inc.68 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2010年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
3,000
试验地点
68

研究概览

简要总结

Prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices.

详细描述

The COMPLETE registry is a prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices. The registry will enroll newly-diagnosed patients with PTCL treated with a variety of regimens. The COMPLETE registry is designed to better understand PTCL patient characteristics, treatments, and outcomes to help design and understand future clinical trials.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient is newly diagnosed with Peripheral T-cell Lymphoma (PTCL):
  • Aggressive natural killer (NK)-cell leukemia
  • Adult T-cell lymphoma/leukemia (human T-cell leukemia virus [HTLV] 1+)
  • Angioimmunoblastic T-cell lymphoma
  • Anaplastic large cell lymphoma (ALCL), primary systemic type (ALK+, ALK-)
  • PTCL, not otherwise specified (NOS)
  • T/NK-cell lymphoma, nasal type
  • Enteropathy-type intestinal lymphoma
  • Hepatosplenic T-cell lymphoma
  • Subcutaneous panniculitis T-cell lymphoma
  • Transformed mycosis fungoides (at diagnosis of transformation)
  • T-cell prolymphocytic leukemia (T-PLL)
  • Cutaneous gamma/delta (γ/δ) T-cell lymphoma
  • Cutaneous aggressive CD8+ T-cell lymphoma
  • Hematodermic neoplasms (blastic plasmacytoid dendritic cell neoplasm)
  • Systemic Epstein Barr Virus (EBV)+ T-cell lymphomas (T-cell lymphoproliferative disorders of childhood)
  • Other T-Cell lymphomas that are not listed in the Exclusion Criteria
  • Patient gives written informed consent

排除标准

  • Patient has other T- or NK-cell malignancies including:
  • Precursor T/NK neoplasms
  • T-cell large granular lymphocytic leukemia
  • Mycosis fungoides, other than transformed mycosis fungoides
  • Sézary syndrome
  • Primary cutaneous CD30+ disorders: ALCL and lymphomatoid papulosis

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (68)

Loading locations...

相似试验